Pharmacy Shanghai University medicine & healthy Sciences China
Dr. Bin Hui is an Associate Professor in the Pharmacology Department at Shanghai University of Medicine & Health Sciences. With a strong background in neuropharmacology and traditional Chinese medicine, he has made significant contributions to pharmacological research, particularly in addiction studies, neuroinflammation, and drug discovery. His academic journey spans multiple prestigious institutions, and he has held key leadership positions, including Vice Dean of the School of Pharmacy.
Profile
Google Scholar
Education 📚
- Bachelor of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine (1996)
- Master of Pharmacology, Lanzhou University (2002)
- Ph.D. in Neuropharmacology, Ocean University of China (2005)
Professional Experience 🎓
- Postdoctoral Training, Fudan University (2005-2007)
- Associate Professor (Pharmacology), Jiaxing University (2007-2015)
- Associate Professor (Pharmacology), Shanghai University of Medicine & Health Sciences (2015-Present)
- Visiting Scholar, Miller Medical School, Miami University (2010-2016)
- Visiting Associate Professor, UCSF, Neuropharmacology (2017-2018)
- Vice Dean, School of Pharmacy, Shanghai University of Medicine & Health Sciences (2015-Present)
Research Interests 🌐
Dr. Hui’s research primarily focuses on:
- Histone acetylation modifications in drug addiction
- Neuroinflammatory mechanisms and neuroprotection
- Development of novel anti-inflammatory and neuroprotective drugs
- Pharmacological applications of traditional Chinese medicine
- Molecular mechanisms of neurodegenerative diseases
Awards & Honors 🏆
- Recipient of multiple research grants from the National Natural Science Foundation of China
- Recognized for contributions in neuropharmacology and addiction research
- Prestigious awards for excellence in pharmacological studies
Publications Top Notes: 📚
Dr. Hui has published extensively in high-impact journals. Below are some of his notable works:
Hui B, Cui LY, Guo RF. “Building an Application-Oriented Pharmaceutical Laboratory Safety and Ethics Education System Based on EHS Principles: Challenges and Strategies.” Journal of Academic Ethics, 2025. DOI: 10.1007/s10805-025-09609-z
Chen Y, Mu W, Wu Y, Xu J, et al. “Optogenetically modified human embryonic stem cell-derived otic neurons establish functional synaptic connection with cochlear nuclei.” J Tissue Eng, 2024.
Hui B, Zhang L, Zhou Q, et al. “Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-kappaB and AP-1 Signaling Pathways In Vitro.” Neurotox Res, 2018. (Cited by 2018 articles)
Hui B, Xia W, Li J, et al. “Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.” J Neurochem, 2006.
Hui B, Yao X, Zhou Q, Wu Z, Sheng P, Zhang L. “Pristimerin, a natural anti-tumor triterpenoid, inhibits LPS-induced TNF-alpha and IL-8 production through down-regulation of ROS-related classical NF-kappaB pathway in THP-1 cells.” Int Immunopharmacol, 2014.
Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells
An extraordinary case associated with an allergic reaction to clopidogrel: coronary artery spasm or Kounis syndrome?
Histone H3 phosphoacetylation is critical for heroin-induced place preference